RFC
KERX

Russell Frank Company’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Russell Frank Company’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-316,518
Closed -$1.11M – 3078
2015
Q3 		$1.11M Sell
316,518
-283,493
-47% -$1.9M ﹤0.01% 2149
2015
Q2 		$5.99M Buy
600,011
+420,342
+234% +$4.51M 0.01% 1308
2015
Q1 		$2.29M Buy
+179,669
New +$2.31M ﹤0.01% 1696
2014
Q4 		– Sell
-1,603
Closed -$22K – 3073
2014
Q3 		$22K Sell
1,603
-121,051
-99% -$1.85M ﹤0.01% 2777
2014
Q2 		$1.89M Sell
122,654
-33,428
-21% -$474K ﹤0.01% 1785
2014
Q1 		$2.21M Buy
156,082
+11,517
+8% +$174K ﹤0.01% 1718
2013
Q4 		$2.24M Sell
144,565
-36,359
-20% -$434K ﹤0.01% 1653
2013
Q3 		$1.83M Sell
180,924
-25,877
-13% -$230K ﹤0.01% 1911
2013
Q2 		$1.54M Buy
+206,801
New +$1.62M ﹤0.01% 1895

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Russell Frank Company's KERX Position: Q4 2015 in Review

Russell Frank Company sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2015, closing a stake of 316,518 shares — an estimated $1.11M sold.

Russell Frank Company first reported a position in KERX in Q2 2013 and held it in 9 quarters. The position peaked at $5.99M in Q2 2015. 128 funds tracked by Wall St. Rank hold KERX as of Q4 2015.

  • Russell Frank Company reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2015 after selling out during the quarter.
  • Russell Frank Company sold 316,518 Keryx Biopharmaceuticals Inc shares in Q4 2015, an estimated $1.11M.
  • Russell Frank Company first reported a position in Keryx Biopharmaceuticals Inc in Q2 2013 and held it in 9 quarters.
  • Russell Frank Company's Keryx Biopharmaceuticals Inc position peaked at $5.99M in Q2 2015.
  • 128 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2015.

Based on Russell Frank Company's 13F filing for Q4 2015, filed 27 Jan 2016.